Sackett NB

Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA; Center for Novel Therapeutics in Addiction Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.

2 papers · 1 preprint · ORCID

ArticlePsilocybin

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.

Sabé M, Grof P, Sackett NB +24

Europe PMC2026
PreprintIbogaine

A Thematic Analysis of the Subjective Effects and Phenomenology of Ibogaine Administered in a Clinical Setting

Torre JL, Cheung SM, Kam A +1

Europe PMC2025
ArticlePsilocybin

Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.

Barnett BS, Bassir Nia A, Sackett NB +1

Europe PMC2023